APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pain Management

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pain Management Market Outlook and Growth Opportunities 2026

20 December 2025190 pages

Choose your research edition.

Industry ResearchPain Management Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Pain Management Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Pain Management Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pain Management Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pain Management Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pain Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pain Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pain Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pain Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pain Management market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pain Management market include Yunnan Baiyao, Teva, Sanofi, J&J, Merck, Eli Lilly, Pfizer, GSK and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pain Management market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pain Management and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pain Management revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pain Management market.

Pain Management Segment by Company

Yunnan Baiyao

Teva

Sanofi

J&J

Merck

Eli Lilly

Pfizer

GSK

Bayer

AstraZeneca

Purdue

Grunenthal

Endo

Depomed

Allergan

Pain Management Segment by Type

Branded Opioids

NSAIDs

Generic Opioids

Others

Pain Management Segment by Application

Hospitals

Clinics

Others

Pain Management Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Pain Management status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pain Management key companies, revenue, market share, and recent developments.

3. To split the Pain Management breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pain Management market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pain Management significant trends, drivers, influence factors in global and regions.

6. To analyze Pain Management competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pain Management and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Management.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pain Management industry.

Chapter 3: Detailed analysis of Pain Management company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pain Management in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pain Management in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pain Management Industry Trends Table 2. Pain Management Industry Drivers Table 3. Pain Management Industry Opportunities and Challenges Table 4. Pain Management Industry Restraints Table 5. Global Pain Management Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pain Management Revenue Share by Company (2021-2026) Table 7. Global Pain Management Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pain Management Key Company Manufacturing Base & Headquarters Table 9. Global Pain Management Company, Product Type & Application Table 10. Global Pain Management Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pain Management by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Branded Opioids Table 15. Significant Companies of NSAIDs Table 16. Significant Companies of Generic Opioids Table 17. Significant Companies of Others Table 18. Global Pain Management Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pain Management Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Pain Management Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Pain Management Sales Value Share by Type (2021-2026) Table 22. Global Pain Management Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospitals Table 24. Significant Companies of Clinics Table 25. Significant Companies of Others Table 26. Global Pain Management Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pain Management Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Pain Management Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Pain Management Sales Value Share by Application (2021-2026) Table 30. Global Pain Management Sales Value Share by Application (2027-2032) Table 31. Global Pain Management Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pain Management Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Pain Management Sales Value Share by Region (2021-2026) Table 34. Global Pain Management Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Pain Management Sales Value Share by Region (2027-2032) Table 36. Global Pain Management Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Pain Management Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Pain Management Sales Value Market Share by Country (2021-2026) Table 39. Global Pain Management Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Pain Management Sales Value Market Share by Country (2027-2032) Table 41. Yunnan Baiyao Company Information Table 42. Yunnan Baiyao Business Overview Table 43. Yunnan Baiyao Pain Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Yunnan Baiyao Pain Management Product Portfolio Table 45. Yunnan Baiyao Recent Development Table 46. Teva Company Information Table 47. Teva Business Overview Table 48. Teva Pain Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Teva Pain Management Product Portfolio Table 50. Teva Recent Development Table 51. Sanofi Company Information Table 52. Sanofi Business Overview Table 53. Sanofi Pain Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Sanofi Pain Management Product Portfolio Table 55. Sanofi Recent Development Table 56. J&J Company Information Table 57. J&J Business Overview Table 58. J&J Pain Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. J&J Pain Management Product Portfolio Table 60. J&J Recent Development Table 61. Merck Company Information Table 62. Merck Business Overview Table 63. Merck Pain Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Merck Pain Management Product Portfolio Table 65. Merck Recent Development Table 66. Eli Lilly Company Information Table 67. Eli Lilly Business Overview Table 68. Eli Lilly Pain Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Eli Lilly Pain Management Product Portfolio Table 70. Eli Lilly Recent Development Table 71. Pfizer Company Information Table 72. Pfizer Business Overview Table 73. Pfizer Pain Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Pfizer Pain Management Product Portfolio Table 75. Pfizer Recent Development Table 76. GSK Company Information Table 77. GSK Business Overview Table 78. GSK Pain Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. GSK Pain Management Product Portfolio Table 80. GSK Recent Development Table 81. Bayer Company Information Table 82. Bayer Business Overview Table 83. Bayer Pain Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Bayer Pain Management Product Portfolio Table 85. Bayer Recent Development Table 86. AstraZeneca Company Information Table 87. AstraZeneca Business Overview Table 88. AstraZeneca Pain Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. AstraZeneca Pain Management Product Portfolio Table 90. AstraZeneca Recent Development Table 91. Purdue Company Information Table 92. Purdue Business Overview Table 93. Purdue Pain Management Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Purdue Pain Management Product Portfolio Table 95. Purdue Recent Development Table 96. Grunenthal Company Information Table 97. Grunenthal Business Overview Table 98. Grunenthal Pain Management Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Grunenthal Pain Management Product Portfolio Table 100. Grunenthal Recent Development Table 101. Endo Company Information Table 102. Endo Business Overview Table 103. Endo Pain Management Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Endo Pain Management Product Portfolio Table 105. Endo Recent Development Table 106. Depomed Company Information Table 107. Depomed Business Overview Table 108. Depomed Pain Management Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Depomed Pain Management Product Portfolio Table 110. Depomed Recent Development Table 111. Allergan Company Information Table 112. Allergan Business Overview Table 113. Allergan Pain Management Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Allergan Pain Management Product Portfolio Table 115. Allergan Recent Development Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Pain Management Product Image Figure 2. Global Pain Management Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pain Management Market Size (2021-2032) & (US$ Million) Figure 4. Global Pain Management Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Branded Opioids Image Figure 8. NSAIDs Image Figure 9. Generic Opioids Image Figure 10. Others Image Figure 11. Global Pain Management Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pain Management Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Pain Management Sales Value Share by Type (2021-2032) Figure 14. Hospitals Image Figure 15. Clinics Image Figure 16. Others Image Figure 17. Global Pain Management Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pain Management Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Pain Management Sales Value Share by Application (2021-2032) Figure 20. Global Pain Management Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Pain Management Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Pain Management Sales Value (2021-2032) & (US$ Million) Figure 23. North America Pain Management Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Pain Management Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Pain Management Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Pain Management Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Pain Management Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Pain Management Sales Value (2021-2032) & (US$ Million) Figure 29. South America Pain Management Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Pain Management Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Pain Management Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Pain Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Pain Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Pain Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Branded Opioids
  • NSAIDs
  • Generic Opioids
  • Others
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Yunnan Baiyao
  • Teva
  • Sanofi
  • J&J
  • Merck
  • Eli Lilly
  • Pfizer
  • GSK
  • Bayer
  • AstraZeneca
  • Purdue
  • Grunenthal
  • Endo
  • Depomed
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pain Management Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pain Management Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pain Management Market Dynamics
  1. 2.1 Pain Management Industry Trends
  2. 2.2 Pain Management Industry Drivers
  3. 2.3 Pain Management Industry Opportunities and Challenges
  4. 2.4 Pain Management Industry Restraints
3 Pain Management Market by Company
  1. 3.1 Global Pain Management Company Revenue Ranking in 2025
  2. 3.2 Global Pain Management Revenue by Company (2021-2026)
  3. 3.3 Global Pain Management Company Ranking (2024-2026)
  4. 3.4 Global Pain Management Company Manufacturing Base and Headquarters
  5. 3.5 Global Pain Management Company Product Type and Application
  6. 3.6 Global Pain Management Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pain Management Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pain Management Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pain Management Market by Type
  1. 4.1 Pain Management Type Introduction
  2. 4.1.1 Branded Opioids
  3. 4.1.2 NSAIDs
  4. 4.1.3 Generic Opioids
  5. 4.1.4 Others
  6. 4.2 Global Pain Management Sales Value by Type
  7. 4.2.1 Global Pain Management Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pain Management Sales Value by Type (2021-2032)
  9. 4.2.3 Global Pain Management Sales Value Share by Type (2021-2032)
5 Pain Management Market by Application
  1. 5.1 Pain Management Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Pain Management Sales Value by Application
  6. 5.2.1 Global Pain Management Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pain Management Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pain Management Sales Value Share by Application (2021-2032)
6 Pain Management Regional Value Analysis
  1. 6.1 Global Pain Management Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pain Management Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pain Management Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pain Management Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pain Management Sales Value (2021-2032)
  7. 6.3.2 North America Pain Management Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pain Management Sales Value (2021-2032)
  10. 6.4.2 Europe Pain Management Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pain Management Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pain Management Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pain Management Sales Value (2021-2032)
  16. 6.6.2 South America Pain Management Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pain Management Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pain Management Sales Value Share by Country, 2025 VS 2032
7 Pain Management Country-level Value Analysis
  1. 7.1 Global Pain Management Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pain Management Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pain Management Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pain Management Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pain Management Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pain Management Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pain Management Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pain Management Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pain Management Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pain Management Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pain Management Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pain Management Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pain Management Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pain Management Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pain Management Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pain Management Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pain Management Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pain Management Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pain Management Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pain Management Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pain Management Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pain Management Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pain Management Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pain Management Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pain Management Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pain Management Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pain Management Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pain Management Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pain Management Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pain Management Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pain Management Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pain Management Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pain Management Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pain Management Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pain Management Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pain Management Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pain Management Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pain Management Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pain Management Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pain Management Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pain Management Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pain Management Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pain Management Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pain Management Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pain Management Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pain Management Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pain Management Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pain Management Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pain Management Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pain Management Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pain Management Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pain Management Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pain Management Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pain Management Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pain Management Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pain Management Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pain Management Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pain Management Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pain Management Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pain Management Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pain Management Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pain Management Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pain Management Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pain Management Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pain Management Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pain Management Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pain Management Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pain Management Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pain Management Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pain Management Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pain Management Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pain Management Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pain Management Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pain Management Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pain Management Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pain Management Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pain Management Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pain Management Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pain Management Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pain Management Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pain Management Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pain Management Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pain Management Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pain Management Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pain Management Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pain Management Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pain Management Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pain Management Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yunnan Baiyao
  2. 8.1.1 Yunnan Baiyao Company Information
  3. 8.1.2 Yunnan Baiyao Business Overview
  4. 8.1.3 Yunnan Baiyao Pain Management Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yunnan Baiyao Pain Management Product Portfolio
  6. 8.1.5 Yunnan Baiyao Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Pain Management Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Pain Management Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Pain Management Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Pain Management Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 J&J
  20. 8.4.1 J&J Company Information
  21. 8.4.2 J&J Business Overview
  22. 8.4.3 J&J Pain Management Revenue and Gross Margin (2021-2026)
  23. 8.4.4 J&J Pain Management Product Portfolio
  24. 8.4.5 J&J Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Pain Management Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Pain Management Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Eli Lilly
  32. 8.6.1 Eli Lilly Company Information
  33. 8.6.2 Eli Lilly Business Overview
  34. 8.6.3 Eli Lilly Pain Management Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eli Lilly Pain Management Product Portfolio
  36. 8.6.5 Eli Lilly Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Pain Management Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Pain Management Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 GSK
  44. 8.8.1 GSK Company Information
  45. 8.8.2 GSK Business Overview
  46. 8.8.3 GSK Pain Management Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GSK Pain Management Product Portfolio
  48. 8.8.5 GSK Recent Developments
  49. 8.9 Bayer
  50. 8.9.1 Bayer Company Information
  51. 8.9.2 Bayer Business Overview
  52. 8.9.3 Bayer Pain Management Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bayer Pain Management Product Portfolio
  54. 8.9.5 Bayer Recent Developments
  55. 8.10 AstraZeneca
  56. 8.10.1 AstraZeneca Company Information
  57. 8.10.2 AstraZeneca Business Overview
  58. 8.10.3 AstraZeneca Pain Management Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AstraZeneca Pain Management Product Portfolio
  60. 8.10.5 AstraZeneca Recent Developments
  61. 8.11 Purdue
  62. 8.11.1 Purdue Company Information
  63. 8.11.2 Purdue Business Overview
  64. 8.11.3 Purdue Pain Management Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Purdue Pain Management Product Portfolio
  66. 8.11.5 Purdue Recent Developments
  67. 8.12 Grunenthal
  68. 8.12.1 Grunenthal Company Information
  69. 8.12.2 Grunenthal Business Overview
  70. 8.12.3 Grunenthal Pain Management Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Grunenthal Pain Management Product Portfolio
  72. 8.12.5 Grunenthal Recent Developments
  73. 8.13 Endo
  74. 8.13.1 Endo Company Information
  75. 8.13.2 Endo Business Overview
  76. 8.13.3 Endo Pain Management Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Endo Pain Management Product Portfolio
  78. 8.13.5 Endo Recent Developments
  79. 8.14 Depomed
  80. 8.14.1 Depomed Company Information
  81. 8.14.2 Depomed Business Overview
  82. 8.14.3 Depomed Pain Management Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Depomed Pain Management Product Portfolio
  84. 8.14.5 Depomed Recent Developments
  85. 8.15 Allergan
  86. 8.15.1 Allergan Company Information
  87. 8.15.2 Allergan Business Overview
  88. 8.15.3 Allergan Pain Management Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Allergan Pain Management Product Portfolio
  90. 8.15.5 Allergan Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst